Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies.
The multipotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source of stem cells for transplant therapies and of vital importance given the shortage in organ donation. Recent studies suggest some immune privilege associated with hESC-derived tissues. Howev...
Autors principals: | Priddle, H, Jones, DR, Burridge, P, Patient, R |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2006
|
Ítems similars
-
Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.
per: Lui, K, et al.
Publicat: (2009) -
In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis
per: Stijn Vanhee, et al.
Publicat: (2015-02-01) -
Mouse and human embryonic stem cell models of hematopoiesis: past, present, and future
per: Dong Chen, et al.
Publicat: (2003-12-01) -
Human embryonic stem cells /
per: Chiu, Arlene Y., et al.
Publicat: (2003) -
Efficient and Fast Differentiation of Human Neural Stem Cells from Human Embryonic Stem Cells for Cell Therapy
per: Xinxin Han, et al.
Publicat: (2017-01-01)